Given that HAPLN1 acts through TGFB signaling52–54, which enhances lectican gene expression53, 55, we also examined whether RSP injection of TGFB1 or TGFB2 can also attenuate PNN degradation and rescue the memory impairments. The gene discussed is HAPLN1; the disease is memory impairment.